Boston, MA -- (SBWIRE) -- 08/29/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: (EXCO Resources Inc (NYSE:XCO), Celldex Therapeutics, Inc. (NASDAQ:CLDX), Ann Inc(NYSE:ANN), Organovo Holdings Inc (NYSEMKT:ONVO)
EXCO Resources Inc (NYSE:XCO) shares dropped 0.27% to $7.31. The company on August 5 announced second quarter results for 2013. Adjusted net income was $0.10 per diluted share for the second quarter 2013 compared with $0.05 per diluted share for the second quarter 2012. GAAP results were net income of $86 million, or $0.40 per diluted share, for the second quarter 2013 compared with a net loss of $496 million, or $2.32 per diluted share, for the second quarter 2012.
How Should Investors Trade XCO After The Recent Volatility? Get Free Report Here
Celldex Therapeutics, Inc. (NASDAQ:CLDX) shares fell 0.36% to $21.88. The company on August 12 said it recently completed enrollment in an initial cohort (n=25) of Avastin® (bevacizumab) refractory patients in the Company's ongoing ReACT study of rindopepimut in EGFRvIII (v3)-positive glioblastoma (GBM). Based on early evidence of anti-tumor activity, including stable disease, tumor shrinkage and investigator-reported response, the Company has decided to add an expansion cohort of approximately 75 patients to better characterize the potential activity of rindopepimut in this refractory patient population. Enrollment in the expansion cohort has begun and, like the initial cohort, will evaluate rindopepimut plus Avastin.
How Should Investors Trade CLDX After The Recent Volatility? Get Free Report Here
Ann Inc(NYSE:ANN) shares increased 2.13% to $34.11. Janney Montgomery Scott upgraded Ann Inc. (NYSE: ANN) from Neutral to Buy with a fair value target of $38.00 (from $33.00), citing compelling valuation and limited downside on August 20.
Additionally, the company on August 23 reported results for the fiscal second quarter of 2013, ended August 3, 2013. The Company also provided its outlook for the third quarter and raised its outlook for the full year of fiscal 2013. For the fiscal second quarter of 2013, the Company reported record earnings per diluted share of $0.76, an increase of 21 percent compared with earnings per diluted share of $0.63 in the second quarter of 2012.
Is ANN A Good Buy After The Recent Price Movement? Find Out Here
Organovo Holdings Inc (NYSEMKT:ONVO) stock fell 4.27% and closed at $5.60. The company on August 12 reported on its financial results for the three-month period ended June 30, 2013. For the three months ended June 30, 2013, total revenues were approximately $0.1 million were $0.2 million or 67% below the approximately $0.3 million in revenues for the same period in 2012. The Company also had negative cash flow from operations of $2.7 million during the three months ended June 30, 2013, with end-of-period cash and cash equivalents of approximately $12.8 million and an accumulated deficit of $70.1 million.
Is ONVO A Strong Buy? Get Advantage Of Our Free Trend Analysis Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)